Beijing Inno Medicine Co., Ltd.

This study is testing if an experimental drug called YN001, given by IV infusion, can safely reduce the amount of plaque that builds up inside heart arteries. It will involve 24 adults in Australia who have coronary artery disease and are already taking a standard cholesterol-low…

This is a very early, first-in-human study to understand how a new drug called YN001 moves through the body and how safe it is. It will involve 24 healthy adult volunteers who will receive a single dose. The main goal is to measure the drug's levels in the blood over time and che…